Concepedia

Publication | Open Access

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

DOIFull Paper Access

31

Citations

25

References

2013

Year

Shitalkumar Zambad, Davinder Tuli, A Matur, Sameer Ghalsasi, Anita Chaudhary, Shailesh Deshpande, Ramesh C. Gupta, Vijay Chauthaiwale, Chaitanya Dutt
Diabetes Metabolic Syndrome and Obesity

Abstract

This study highlights the potential of TRC210258, a novel TGR5 agonist, to improve dyslipidemic cardiovascular risk beyond glycemic control in patients with type 2 diabetes.

References

YearCitations

Page 1